Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
- PMID: 32062311
- DOI: 10.1016/j.critrevonc.2019.102862
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
Abstract
The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the diagnosis and treatment of patients with early and locally advanced non-small cell lung cancer. In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed these topics, analyzing available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
Keywords: Clinical practice guidelines; Early disease; Locally advanced disease; Non-small cell lung cancer; Recommendations.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest Silvia Novello, Department of Oncology, University of Turin, AOU San Luigi, Orbassano (Italy). COI: consultant and/or speaker's fee for Eli Lilly, MSD, Roche, BMS, Takeda, Pfizer, Abbvie, Celgene, AZ, Boehringer Ingelheim.
Similar articles
-
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.Crit Rev Oncol Hematol. 2020 Feb;146:102858. doi: 10.1016/j.critrevonc.2019.102858. Epub 2019 Dec 28. Crit Rev Oncol Hematol. 2020. PMID: 31918343 Review.
-
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study.Lung Cancer. 2015 Nov;90(2):234-42. doi: 10.1016/j.lungcan.2015.08.005. Epub 2015 Aug 19. Lung Cancer. 2015. PMID: 26314614
-
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21. doi: 10.1093/annonc/mdx222. Ann Oncol. 2017. PMID: 28881918 No abstract available.
-
Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM).Tumori. 2019 Jul;105(5_suppl):3-14. doi: 10.1177/0300891619857418. Tumori. 2019. PMID: 31264531
-
Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.Lung Cancer. 2010 Jun;68(3):319-31. doi: 10.1016/j.lungcan.2009.11.018. Epub 2009 Dec 24. Lung Cancer. 2010. PMID: 20036027 Review.
Cited by
-
Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method.Molecules. 2023 Mar 14;28(6):2618. doi: 10.3390/molecules28062618. Molecules. 2023. PMID: 36985590 Free PMC article.
-
Optimizing Lung Cancer Diagnostics: Insights from a Fast-Track Program in a Complex Healthcare Setting.Life (Basel). 2025 Feb 25;15(3):362. doi: 10.3390/life15030362. Life (Basel). 2025. PMID: 40141706 Free PMC article.
-
Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC.Open Med (Wars). 2021 Aug 26;16(1):1265-1275. doi: 10.1515/med-2021-0260. eCollection 2021. Open Med (Wars). 2021. PMID: 34514171 Free PMC article.
-
The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review.Cancers (Basel). 2023 Apr 26;15(9):2476. doi: 10.3390/cancers15092476. Cancers (Basel). 2023. PMID: 37173943 Free PMC article. Review.
-
GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer.World J Clin Oncol. 2022 Apr 24;13(4):237-266. doi: 10.5306/wjco.v13.i4.237. World J Clin Oncol. 2022. PMID: 35582651 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical